Literature DB >> 16831049

Atypical small acinar proliferation in the prostate: clinical significance in 2006.

David G Bostwick1, Isabelle Meiers.   

Abstract

About 2% of contemporary prostate needle biopsy specimens contain collections of small acini that are suspicious for cancer but that fall below the diagnostic threshold and are reported as atypical small acinar proliferation suspicious for but not diagnostic of malignancy. Prostate cancer has been identified in specimens from subsequent biopsies in up to 60% of cases of atypical small acinar proliferation, indicating that this finding is a significant predictor of cancer. Identification of atypical small acinar proliferation warrants repeat biopsy for concurrent or subsequent invasive carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16831049     DOI: 10.5858/2006-130-952-ASAPIT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials.

Authors:  Naoto Kuroda; Kazunobu Katto; Masato Tamura; Tomoyuki Shiotsu; Shoichiro Nakamura; Yuji Ohtsuki; Ondrej Hes; Michal Michal; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

2.  Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.

Authors:  Peter H Gann; Angela Fought; Ryan Deaton; William J Catalona; Edward Vonesh
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

Review 3.  [Diagnostic of prostate cancer: conventional and molecular or cell biological methods].

Authors:  M Susani; L Kenner; Z Culig
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

4.  High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.

Authors:  Nermina Obralic; Benjamin Kulovac
Journal:  Bosn J Basic Med Sci       Date:  2011-11       Impact factor: 3.363

Review 5.  Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.

Authors:  A Leone; B Gershman; K Rotker; C Butler; J Fantasia; A Miller; A Afiadata; A Amin; A Zhou; Z Jiang; T Sebo; A Mega; S Schiff; G Pareek; D Golijanin; J Yates; R J Karnes; J Renzulli
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-11-17       Impact factor: 5.554

6.  Prostate gland biopsies and prostatectomies: an Ontario community hospital experience.

Authors:  Ken J Newell; John F Amrhein; Rashmikant J Desai; Paul F Middlebrook; Todd M Webster; Barry W Sawka; Brian F Rudrick
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

7.  Audit of rapid access introduction reveals high prevalence of prostate cancer in Western Region.

Authors:  E M Bolton; B D Kelly; M R Quinlan; F T D'Arcy; M Azar; C M Dowling; M Power; P McCarthy; C Roche; K Walsh; E Rogers; G C Durkan
Journal:  Ir J Med Sci       Date:  2013-07-19       Impact factor: 1.568

8.  Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy.

Authors:  Katia Ramos Moreira Leite; Luiz Heraldo Camara-Lopes; José Cury; Marcos F Dall'oglio; Adriana Sañudo; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

9.  An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.

Authors:  Sudhir Perincheri; Angelique Wolf Levi; Romulo Celli; Peter Gershkovich; David Rimm; Jon Stanley Morrow; Brandon Rothrock; Patricia Raciti; David Klimstra; John Sinard
Journal:  Mod Pathol       Date:  2021-03-29       Impact factor: 7.842

10.  Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer.

Authors:  Andrew Leone; Katherine Rotker; Christi Butler; Anthony Mega; Jianhong Li; Ali Amin; Stephen F Schiff; Gyan Pareek; Dragan Golijanin; Joseph F Renzulli
Journal:  Prostate Cancer       Date:  2015-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.